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Welcome to the New Year and a new issue of the Biomedical Journal, where we learn that
travelling with company boosts the metastatic potential of circulating tumour cells, as well
as that a worm could be an excellent model to study antidiabetic drugs. In addition, we
discover another pair of molecular scissors for genetic engineering, how exactly Leptospira
wreaks havoc on its run through the host organism, and that hyperparathyroidism brings
its own risks, but does not worsen the outcome of papillary thyroid carcinoma. Further-
more, the importance of taking into account differing beauty ideals for aesthetic surgery
surveys is discussed, alongside the question how bad isolated local recurrence is in the
case of HR þ breast cancer. Finally, we find out that virtual colonoscopy deserves more
credit, that the first medical experiment in space was all about the H-reflex, and that it is
possible to survive advanced necrotising fasciitis of the face and neck.Spotlight on reviews
Tumour travel tours e why circulating cancer cells value
company
Everybody needs a friend, claimed the iconic landscape painter
Bob Ross in one of his tutorials. Rosswas speaking of trees, but
everyone who has to deal with cell culture knows perfectly
well that cells too need company, either in the form of dense
seeding, feeder cells, or molecular tricks like adding Rock in-
hibitor to themedium [1]. Especially stem cells are particularly
sensitive to loneliness, which makes them either die or
differentiate [2]. Circulating tumour cells (CTCs), the offspring
of the primary tumour that set out into the bloodstream andResearch & Innovation C
.
g Gung University.
ublishing services by Else
s/by-nc-nd/4.0/).lymphatic system to instigate metastases, may be the ulti-
mate villains, but no exception to the rule, as Nicola Aceto
explains in his review [3].
By now, it is well accepted that the tumour microenvi-
ronment and host immune system can be serious accomplices
during primary cancer growth [4]. Twelve years ago, it was
shown that the simple co-injection ofmatrigel potentiated the
tumorigenic abilities of a large fraction of melanoma cells,
thus triggering the contestation of the cancer stem cell su-
premacy [5]. To date, the tumour niche is intensely studied, as
it became clear that this complex mixture of endothelial cells,
fibroblasts and immune cells contributes greatly to many
cancer hallmarks: angiogenesis, chronic inflammation, stem
cell-like properties and growth signalling [6]. Unsurprisingly,
this got it also straight into the therapeutic firing line [7].entre, Anders Lund Group, Ole Maaløes Vej 5, 2200, Copenhagen,
vier B.V. This is an open access article under the CC BY-NC-ND
b i om e d i c a l j o u r n a l 4 3 ( 2 0 2 0 ) 1e72Cancer and the immune system, for their part, have an
even more complicated relationship. On the one hand, cancer
immunotherapy carries currently the highest hopes on its
shoulders, with sophisticated methods such as chimeric an-
tigen receptor T cells, or specific antibody therapies [8]. On the
other hand, most solid tumours are extremely talented at
subverting members of the immune system, including mac-
rophages, neutrophils, and T cells [9]. Macrophage infiltration
for example foreshadows bad prognosis, as it stimulates
angiogenesis, tumour cell survival and extravasation [10].
What exactly happens once a cancer cell decides to leave
the nest however remains more elusive, as CTCs are sparse,
mobile, and hidden amidst the bloodstream. The fact that
CTCs can bring company however has been theorised a long
time ago, but experimentally proven only recently to be shed
by many different cancers. Aceto explains the technological
innovations that made the latter possible, and outlines the
two main strategies in use, based either on antigenic staining
or size selection by microfluidics. Subsequently, he outlines
the biological features of homotypic clusters, composed of
cancer cells only, and heterotypic clusters, a mix of cancerFig. 1 Cluster formation potentiates the metastatic potential of ci
cells that have migrated from the primary tumour into the blood
distant sites. Clustering with other tumour cells (homotypic), or
improves CTC fitness and fastens engraftment, thus increasing th
better patient stratification or to gain information on the tumour
lower the metastatic risk.with stromal or immune cells. A key feature of homotypic CTC
clusters is the presence of intercellular junctions, a feature
that rings a bell, once again, for embryonic stem cell aficio-
nados. It is no secret that tumour cells frequently highjack
pluripotency pathways for their advantages, such as unlim-
ited proliferation, immortality and sturdy features [11]. As the
author accurately points out, cellecell junctions are required
for the expression of the core set of pluripotency transcription
factors, both in native stem cells and cancer cells. Heterotypic
CTC clusters consist basically in cancer cells bringing along a
little piece of their original stromal niche: fibroblasts, endo-
thelial cells or immune cells. The familiar feeling seems to
have the same comforting effect as the primary tumour
microenvironment, including better survival and boosted
proliferation.
Altogether, travel company, be it by other cancer or stro-
mal cells, appears to have the same downstream effect on
CTCs: faster engraftment due to earlier entrapment in small
blood vessels, increased fitness and dedifferentiated fea-
tures, thus leading to more frequent and aggressive metas-
tases (Fig. 1).rculating tumour cells. Circulating tumour cells (CTCs) are
stream or the lymphatic system and can cause metastasis in
cells from the cancer microenvironment (heterotypic),
eir metastatic potential. CTC cluster detection could serve for
, alternatively targeting CTC clusters for dissociation could
b i om e d i c a l j o u r n a l 4 3 ( 2 0 2 0 ) 1e7 3Now, seen in this way, this is rather depressing news, at
least for the host organism. Aceto attempts nonetheless to
slightly lighten the mood by stressing the diagnostic and
eventual therapeutic value of the CTC cluster discovery.
Diagnostic-wise, they could fine-tune patient stratification
and offer valuable clues on tumour composition and genetics.
Regarding therapeutics, targeting these clusters for dissocia-
tion would be tempting, despite that the technicalities are yet
undetermined.
At any rate, CTCs on the road and eventual travel com-
panions need to be further studied, if we hope to ever develop
an efficient roadblock for them before they settle down.1 wormbase.org.Spotlight on original articles
Send in the worms: using C. elegans in order to understand
anti-diabetic drugs
Syndey Brenner, one of the key figures of the rise of molecular
biology during the 20th century - notably for the discovery of
messenger RNA e received the Noble prize in Physiology or
Medicine in 2002. His Nobel lecture Natures Gift to Science is
dedicated to “the fourth winner of the Nobel prize this year”
[12], and referred to no one else than Caenorhabditis elegans.
In1974, he elected the 1-mm-long roundworm as his model
system of choice in order to study “the complex structures
found in higher organisms”, notably the development of the
nervous system [13]. The tiny worm had the right size for
electron microscopy, lived happily in a dish filled with E.coli,
self-fertilized and produced about 300 new nematodes every
3.5 days [12]. Brenner's first study reported hundreds of mu-
tants and related genes [13]. Since then, C. elegans has become
an evergreen model organism for a broad scientific commu-
nity, and despite the latest trend to go as human-like as
possible for some studies (like miniature brains in a dish [14]),
the worm has never lost its pertinence for the understanding
of both normal ontogenesis and various human pathologies,
including neurodegenerative diseases [15].
Hsiung et al. add another proof for the statement in their
study published in this issue of the Biomedical Journal, by
demonstrating that the nematode can also be used to as a
model for human metabolic failings [16].
Metabolic defects are keystones to countless pathologies,
and their incidence is on the rise, to a degree that many
publications nowadays refer for instance to an ongoing “dia-
betes epidemic” [17]. Only recently though, the central role of
mitochondria in disorders like diabetes and obesity has
received the deserved attention, and been included as a po-
tential therapeutic target [18]. One target might be CISD-1,
termed mitoNEET until not too long ago. It belongs to a
recently discovered family of iron-sulphur proteins (CISD1-3),
which are all linked to the mitochondria in humans, and
implicated in a large array of functions ranging from respira-
tion and iron homeostasis to protein biosynthesis [19]. CISD-1
in particular was detected in 2003, when Colca et al. tried to
decipher the mechanism underlying the beneficial action of
thiazolidinedione against type 2 diabetes, known since the
beginning of the 1980s. It turned out that the drug, thought to
mainly activate the nuclear receptor PPARg, also cross-linkeda novel mitochondrial protein [20]. Nevertheless, it is still
unclear how exactly thiazolidinedione and similar com-
pounds impact on CISD-1, and what the downstream molec-
ular events relevant for diabetes treatment are.
This lingering question prompted Hsiung and colleagues to
look for a suitable in vivo model system that would combine
ease of study with conservation in humans: it was time to call
in the worms.
Not only is the fate of every single cell of C. elegans across
development well studied and documented by now [21], the
scientific worm community has also created valuable data-
bases for any nematode-related eomics, first and foremost
the WormBase website.1 Similar good annotation practices
certainly facilitated the hunt for CISD equivalents, and indeed,
the authors successfully uncovered a homolog for the human
Cisd-1, further referred to as cisd-1, and two homologs for
CISD-3. Expression of a 143 amino acid protein corresponding
to CISD-1 is further confirmed experimentally. Like the
human version, the C. elegans CISD-1 is subsequently shown
by complementary techniques to be located in the outer
mitochondrial membrane.
In order to investigate its function, a CISD-1 mutant is
generatedbydeletingamajorpartof thegene.Surprisingly,both
motility and lifespan of themutant worms does not differ from
the wild-type, however, the authors make an educated guess -
based on location and known function of the homologous pro-
teins - and decide to investigate thoroughly both morphology
and performance of the mitochondria in themutant worms.
Shape and function are known to be closely related for this
special organelle, once an organism on its own, after all [22].
“Function” alone encompasses energy production, cell sig-
nalling, calcium homeostasis, stress regulation and cell death
management. In addition, over the recent years, it has become
clear that mitochondrial shape is a major regulatory factor for
the cellular bioenergetics capacity [23]. In other words, being
in a bad shape has to be taken literally when it comes to this
cellular compartment [24].
As suspected, the CISD-1 mutant mitochondria display a
markedly altered appearance, in the form of a hyperfused
morphology. This kind of phenotype (in this case due to a
DRP1 mutation) has been shown for instance to play a role in
severe axonal neuropathy [25]. Surprisingly though, hyper-
fused mitochondria have also been correlated with longevity,
alongside elevated autophagy activity [26].
Confirming the shape-function connection, the authors
detect elevated reactive oxygen species (ROS) and superoxide
production by the mutant mitochondria, paralleled by a
decrease by half of ATP production, and lower glucose levels.
Lastly, Hsiung et al. show that several anti-diabetic drugs
haveeffects similar to theCISD-1mutationonwild-typeworms,
including mitochondria hyperfusion, as well as a decrease of
ATPandglucose levels. Theseresults in turnsuggest thatCISD-1
is as well the target of these compounds in C. elegans.
In a nutshell, all results boil down to the encouraging
conclusion that the nematode would be a fitting model to
study the CISD-1 and drugs targeting the latter in a setting
mimicking human diabetes.
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The curious Cas(e) of CRISPR-Cas12a: an alternative pair of
molecular scissors
No doubt that the CRISPR-Cas endonucleases, the molecular
tools that allows for cutting double-stranded DNA at an exact
location, are by far the most publicised biomolecular innova-
tion of the recent years, both among the scientific community
and the general public. Sparking hopes and fears worthy of
science fiction novels, the field has already experienced its
share of drama, with the ongoing fight over the patent [27,28],
and scandals, with the generation of the “CRISPR babies”
[29,30]. Nevertheless, apart from having become the new
standard for generating experimental knock-outmodels, solid
proof has been generated that the method holds the potential
to correct serious genetic defaults, such as sickle cell anaemia
[31]. Moreover, “prime editing”, the in situ directed modifica-
tion of single nucleotides without the requirement of the
cellular DNA repair machinery, hit the headlines recently [32].
Most people immediately equateCRISPRCaswith theCas9a
enzyme, which is indeed the most broadly used one, yet the
original inventorsebacteriaandarchaeaepossess twoclasses
and six types of CRISPR-cas systems, and some of thesemight
alsobesuitable tobe repurposed into “molecular scissors”. Paul
andMontoyadedicate their reviewto theclass II typeVCRISPR-
Cas12a system, an alternative, so far underappreciated
genome-editing tool, which has already proven its worth by
correcting muscular dystrophy in human cells and mice [33].
The authors first explain thoroughly how the endonucleases
carry out their native function in procaryotes, followed by a
detailed account on Cas12a structure and operation mode.
Subsequently, by comparing the enzyme with Cas9a, they
highlight its advantages, such as the requirement of only one
RNA molecule and the possibility to perform multiplex gene
regulation, and drawbacks, notably its indiscriminate single
strand DNA cleavage activity [34]. Given that the prime editing
complex is so far extremely hard to get into cells due to its size,
Cas12ahas solid chances to encounter broad applications both
in genome editing and bioengineering.Fast and furious: Leptospira quickly invades the entire host and
causes massive inflammation
Zoonoses, originating from animal to human transmission,
make up for 60% of all infectious diseases e the currently
circulating Wuhan coronavirus is just the latest illustration.
Eradication of the pathogen is almost impossible, as it resides
in a huge reservoir and often does not cause severe symptoms
in the animal host [35]. However, the media-fuelled distortion
of risk assessment regarding the newest recruit to the set
obscures the way deadlier classics of the zoonosis collection.
Sun and colleagues set the number straight by reminding us
that leptospirosis, a systemic inflammatory disease caused by
Leptospira bacteria, claims ten thousand victims per year and
is expanding its operating range [36].
What makes Leptospira a formidable enemy is the fact that
the bacterium is permanently on the move: it quickly trans-
gressess mucosal and skin barriers, pierces through bloodvessels and renal tubule epithelia, spreads in no time to many
organs, as well as the cerebrospinal fluid, and highjacks the
host cell endo- and exocytosis machineries. On the run, Lep-
tospira leaves behind a trail of destruction, both through its
ability to induce apoptosis in multiple cell types, and through
a massive provocation of the host immune system, turning it
into its own enemy by excessive inflammation. Haemorrhage
and multiple organ failure are the worst-case outcome of the
infection, with 50% mortality at this stage [37].
Here, Sun et al. focus on the recent progress made in un-
derstanding Leptospira's virulence factors and their mode of
action. Following the chronology of Leptospira invasion, they
discuss first the role of adherence factors. Invasion comes
next, where Leptospira stands out thanks to its abundance of
metalloproteases. Subsequently, the authors discuss in detail
the different toxins that come into play as soon as the path-
ogen has made its way into the host organism, notably its
sophisticated tools to interfere with blood coagulation.
Finally, Sun et al. list Leptospira's attributes which are
responsible for the massive pro-inflammatory response, and
stress the importance of a better understanding of all the
migratory features of Leptospira in order to stop it in time.
Original articles
Major Tom to Motoneuron: H-reflex depression happens at the
pre-synaptic level
One of the very first medical experiments to be carried out on
the International Space Station (ISS) was the effect of zero
gravity on the Hoffmann's reflex (H-reflex) [38]. A short elec-
trical stimulation of a peripheral nerve elicits first an efferent
response (M-wave) towards the muscle, then an afferent one
towards the corticospinal tract (H-wave), where a motor
neuron is activated, leading to the contraction of the muscle
located at the initial stimulation spot (H-reflex). In addition,
the afferent signal also activates inhibitory interneurons,
which dampen the signal before it travels along the motor
neuron. Repetitive stimulation leads to the depression of the
H-reflex, potentially in order to avoid over-stimulation of the a
motor neuron and the muscle [39]. The system is frequently
disrupted because of spinal disinhibition in various pathol-
ogies, such as diabetic neuropathy [40], or after spinal cord
injury (SCI) [41], leading to spasticity and pain. Despite the
large amount of related studies, it was still unclear whether
the inhibition steps in at the pre- or post-synaptic level. Chang
et al. decided to shed light on the exact mechanism by testing
healthy subjects with a classic rate-sensitive H-reflex, pa-
tients with acute sensory-impaired SCI, and healthy in-
dividuals lacking the rate-sensitive depression. They combine
testing for H-reflex depressionwith recording ofmotor evoked
potentials (MEP) after direct a motor neuron excitation by
transcranial stimulation in all three test groups. Observing no
decrease in MEP in any group, the authors provide the most
solid experimental evidence in humans that the H-reflex takes
place at the pre-synaptic level [42].
The gland next door: does hyperparathyroidism impact on
papillary thyroid carcinoma outcomes?
Thyroid cancer, affecting an endocrine glandwhose hormonal
secretions regulate metabolism and calcium homeostasis, is
2 https://www.wcrf.org/dietandcancer/cancer-trends/
worldwide-cancer-data.
3 https://www.rifters.com/crawl/?p¼1831.
b i om e d i c a l j o u r n a l 4 3 ( 2 0 2 0 ) 1e7 5on the rise worldwide [43]. Papillary thyroid carcinoma (PTC)
is its most frequent subtype, and the standard treatment
consists in surgical removal often followed by radioactive
iodine therapy, with very good chances for remission [44,45].
Parathyroid glands in turn are located directly on the back of
the thyroid, and in charge of regulating blood calcium levels
via the secretion of parathyroid hormone (PTH). Excessive PTH
production, or hyperparathyroidism (HPT), is mostly caused
by benign adenomas, or the consequence of chronic kidney
failure. The resulting perturbation of the calciummetabolism
can cause various complications ranging from weakness to
osteoporosis [46]. Given the physical proximity between the
two glands, as well as some reports linking HPT with several
cancers [47,48], Tsai et al. undertook to retrospectively inves-
tigate if an additional occurrence of hyperparathyroidism
impacts PTC cancer prognosis in the long term. They findings
indicate that hyperparathyroidism occurs in slightly over 1%
OF PTC cases, and has no statistically significant impact on
non-remission risk. However, it correlates with an increased
non-thyroid cancer related mortality in PTC patients, mainly
due to cardiovascular events [49], which are possibly linked to
the defective parathyroid function [50].
Mirror, mirror on the wall: FACE-Q survey validated for
Mandarin Chinese
In the previous issue of the Biomedical Journal, researchers of
the Chang Guang Memorial Hospital in Taiwan emphasized
the importance to take into account the patient's self-
perception before and after orthognathic surgery [51], given
its impact on the individual's quality of life [52]. However,
many aesthetic values are culture-dependent. Thus, this
time, Su et al. ensure that the standard questionnaire “FACE-
Q”, used for auto-evaluation of many types of facial aesthetic
surgeries, and originally written in English [53], meets both
linguistic and psychological requirements after translation
into Mandarin Chinese specifically for the case of orthog-
nathic surgery. The authors confirm both the accuracy of the
translation, the consistency of the system, and its usefulness
in translating the psychological benefit from this type of
surgery [54].
Turning the inside out: how trustworthy is virtual colonoscopy?
Colon polyps, small masses of cells on the lining of the colon,
are mostly harmless. Nevertheless, some can develop into
colon cancer, which ranks 3rd on the list of most frequent
cancers, thus early detection by screening and subsequent
removal are highly recommended [55]. CT colonography, also
called virtual colonoscopy, is an x-ray based imaging pro-
cedure where three-dimensional pictures are reconstituted
from two-dimensional cross-sections. Compared to conven-
tional colonoscopy, the procedure allows for the visualisation
of the entire colon, and is less invasive, discomforting, risky
and costly [56]. Yet it is still regarded with some suspicion,
because it is less precise for small lesions, and sensitive to
image distortion through movement, or computed analysis
mistakes [57]. Subsequent image treatment includes the
subtraction - or segmentation - of other organs, bones and
fluid from the images [58]. Inaccuracies during this process
could lead to measurement errors regarding polyp size and
number, although this issue has never been thoroughlyinvestigated and quantified. For this reason, Manjunath et al.
set out to methodically compare different volume-measure-
ment techniques on available CT colonography datatsets with
and without segmentation. They come to the conclusion that
in all cases, the segmentation proved actually robust and
generated accurate results [59].
Try again e how much bad news are isolated local recurrence
for HR + breast cancer?
Breast cancer remains the most common cancer in women,2
and three quarters of the cases are hormone receptor posi-
tive (HR+), meaning that the tumour cells express the oes-
trogen and/or the progesterone receptor [60]. The
reappearance of cancerous lesions close to the initial tumour
site, termed isolated local recurrence (ILR), after surgery and
postoperative therapy is per se bad news, as half of the cases
tend to develop distant metastasis within five years [61]. Yu et
al. aimed in their present study at determining further fea-
tures that would prognosticate distant metastasis-free and
overall survival (DMFS and OS) outcome in primary
HR + patients with ILR. The authors compare the primary
tumour characteristics, the histological consistency between
the primary and recurrent tumours, aswell as the surgical and
postoperative treatments, and correlate them with the pa-
tients’ outcome. They identify 29 months as the most appro-
priate cut-off for time to ILR to reflect survival. Moreover,
primary tumour size and grading are confirmed to be pre-
dictors for DMFS and OS. In addition, Yu and colleagues
encourage further studies aiming at incorporating novel
agents into hormone therapy, which remains the first choice
of treatment for ILR [62].Brief communication
Rated PG-13: a severe case of facial necrotising fasciitis
“If there was ever a disease fit for a science-fiction writer,
flesh-eating disease got to be it”, wrote Peter Watts in 2011 on
his blog,3 after contracting the disease more correctly called
necrotising fasciitis. In this case, the fatal combination of
breached skin, an underperforming immune system and
various bacteria can sometimes lead to the infection, and
subsequent necrosis of connective tissues, as well as images
that are not for the faint-hearted [63].
In this brief communication, Chou et al. report a case
compiling all textbook worst-case scenarios e an individual
with untreated diabetes, and an advanced stage of necrot-
ising fasciitis of the entire head and neck e with an aston-
ishing good ending. The authors detail the initial findings, as
well as all treatment steps that succeeded in saving the pa-
tient [64].Conflicts of interest
The author declares no conflict of interests.
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